{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:16:15Z","timestamp":1790907375933,"version":"4.1.0"},"reference-count":74,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,6,29]],"date-time":"2005-06-29T00:00:00Z","timestamp":1120003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold>Silymarin from the milk thistle herb (<jats:italic>Silybum marianum<\/jats:italic>) is used by many patients with chronic viral hepatitis, but its efficacy remains unknown. We performed a systematic review of silymarin for the treatment of chronic viral hepatitis B and C. An exhaustive search strategy identified 148 papers that studied silymarin compounds in liver disease. Of these, four trials included patients with hepatitis C, one included hepatitis B patients, and two, unspecified chronic viral hepatitis. However, only one trial exclusively studied patients with hepatitis C, and none involved patients with only hepatitis B. Silymarin treatment resulted in a decrease in serum transaminases compared with baseline in four studies, and compared with placebo in only one study. There is no evidence that silymarin affects viral load or improves liver histology in hepatitis B or C. No studies were found that investigated the use of silymarin concomitantly with interferon, nucleoside analogues, or other conventional treatments for hepatitis B or C. In conclusion, silymarin compounds likely decrease serum transaminases in patients with chronic viral hepatitis, but do not appear to affect viral load or liver histology. Nevertheless it may be worthwhile to determine its effects in conjunction with standard antiviral treatment.<\/jats:p>","DOI":"10.1111\/j.1365-2893.2005.00636.x","type":"journal-article","created":{"date-parts":[[2005,10,17]],"date-time":"2005-10-17T14:47:36Z","timestamp":1129560456000},"page":"559-567","source":"Crossref","is-referenced-by-count":138,"title":["Silymarin treatment of viral hepatitis: a systematic review"],"prefix":"10.1111","volume":"12","author":[{"given":"K. \u00c9.","family":"Mayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,9]]},"reference":[{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00431-2"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg163"},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00010"},{"key":"e_1_2_14_7_2","volume-title":"Milk Thistle. Review of Natural Products. Fact and Comparisons","author":"DerMarderosian A.","year":"2003"},{"key":"e_1_2_14_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07298.x"},{"issue":"9","key":"e_1_2_14_9_2","first-page":"456","article-title":"A pilot study on the liver protective effect of silybin\u2010phosphatidylcholine complex (IdB1016) in chronic active hepatitis","volume":"31","author":"Buzzelli G","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"e_1_2_14_10_2","first-page":"CD003620","article-title":"Milk thistle for alcoholic and\/or hepatitis B or C liver diseases. Cochrane Hepato\u2010Biliary Group","volume":"2","author":"Rambaldi A","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_14_11_2","volume-title":"Milk Thistle: zEffects on Liver Disease and Cirrhosis and Clinical Adverse Effects","author":"Mulrow C","year":"2000"},{"issue":"28","key":"e_1_2_14_12_2","first-page":"1060","article-title":"Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres","volume":"73","author":"Magliulo E","year":"1978","journal-title":"Med Klin"},{"issue":"5","key":"e_1_2_14_13_2","first-page":"318","article-title":"Results of two double\u2010blind studies on the effect of silymarine in chronic hepatitis","volume":"7","author":"Kiesewetter E","year":"1977","journal-title":"Leber Magen Darm"},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01244-5"},{"key":"e_1_2_14_15_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161140-00003"},{"issue":"12","key":"e_1_2_14_16_2","first-page":"513","article-title":"Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial","volume":"72","author":"Bode JC","year":"1977","journal-title":"Med Klin"},{"issue":"1","key":"e_1_2_14_17_2","first-page":"363","article-title":"Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease","volume":"80","author":"Lirussi F","year":"1992","journal-title":"Acta Physiol Hung"},{"issue":"2004","key":"e_1_2_14_18_2","first-page":"491","article-title":"Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review","volume":"40","author":"Thompson Coon J","year":"2003","journal-title":"J Hepatol"},{"key":"e_1_2_14_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.18.1569"},{"issue":"2","key":"e_1_2_14_20_2","first-page":"121","article-title":"Use of alternative medicine by patients attending a gastroenterology clinic","volume":"142","author":"Verhoef MJ","year":"1990","journal-title":"CMAJ"},{"key":"e_1_2_14_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00139.x"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-999-0087-2"},{"key":"e_1_2_14_23_2","first-page":"257","volume-title":"Herbal Medicine: Expanded Commission E monographs","author":"Blumenthal M.","year":"2000"},{"key":"e_1_2_14_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(01)00364-8"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1300\/J157v01n03_08"},{"key":"e_1_2_14_26_2","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200115070-00005"},{"issue":"1","key":"e_1_2_14_27_2","first-page":"S25","article-title":"Properties and medical use of flavonolignans (Silymarin) from Silybum marianum","volume":"10","author":"Leng\u2010Peschlow E","year":"1996","journal-title":"Phytother Res"},{"issue":"1","key":"e_1_2_14_28_2","first-page":"23","article-title":"Silymarin content of different Silybum marianum L. Gaertn. cultivars","volume":"30","author":"Chiavari G","year":"1991","journal-title":"Herba Hungarica"},{"key":"e_1_2_14_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.2650070122"},{"issue":"10","key":"e_1_2_14_30_2","first-page":"655","article-title":"Pharmacokinetic studies with silymarin in human serum and bile","volume":"6","author":"Lorenz D","year":"1984","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03190223"},{"key":"e_1_2_14_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03188811"},{"issue":"3","key":"e_1_2_14_33_2","first-page":"265","article-title":"Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis","volume":"45","author":"Feher J","year":"1988","journal-title":"Acta Medica Hungarica"},{"key":"e_1_2_14_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.879"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230415"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005512014280"},{"key":"e_1_2_14_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(99)00052-1"},{"key":"e_1_2_14_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(94)90006-X"},{"key":"e_1_2_14_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0901-9928.2000.860602.x"},{"issue":"11","key":"e_1_2_14_40_2","first-page":"BR439","article-title":"Immunostimulatory effect of Silybum marianum (milk thistle) extract","volume":"8","author":"Wilasrusmee C","year":"2002","journal-title":"Med Sci Monit"},{"key":"e_1_2_14_41_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.302.1.138"},{"issue":"9","key":"e_1_2_14_42_2","first-page":"933","article-title":"Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis","volume":"12","author":"Singh RP","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_14_43_2","doi-asserted-by":"publisher","DOI":"10.1089\/15230860260220166"},{"key":"e_1_2_14_44_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.30983"},{"key":"e_1_2_14_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00060-0"},{"key":"e_1_2_14_46_2","doi-asserted-by":"publisher","DOI":"10.3109\/10715769709097863"},{"key":"e_1_2_14_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.1999.01928.x"},{"key":"e_1_2_14_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005350070045"},{"key":"e_1_2_14_49_2","first-page":"133","article-title":"In vitro studies on the effect of certain natural products against hepatitis B virus","volume":"92","author":"Mehrotra R","year":"1990","journal-title":"Indian J Med Res"},{"key":"e_1_2_14_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00148-9"},{"key":"e_1_2_14_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200310000-00013"},{"issue":"5","key":"e_1_2_14_52_2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5694\/j.1326-5377.1999.tb140322.x","article-title":"An adverse reaction to the herbal medication milk thistle (Silybum marianum)","volume":"170","author":"Adverse Drug Reactions Advisory Committee","year":"1999","journal-title":"Med J Aust"},{"issue":"10","key":"e_1_2_14_53_2","first-page":"387","article-title":"Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate\u2010type allergy to Kiwi fruit","volume":"13","author":"Geier J","year":"1990","journal-title":"Allergologie"},{"key":"e_1_2_14_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80285-7"},{"issue":"11","key":"e_1_2_14_55_2","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0090-9556(24)15071-4","article-title":"Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures","volume":"28","author":"Venkataramanan R","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_14_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1989.tb00449.x"},{"issue":"2","key":"e_1_2_14_57_2","first-page":"249","article-title":"Protective effect of Legalon in workers exposed to organic solvents","volume":"45","author":"Szilard S","year":"1988","journal-title":"Acta Medica Hungarica"},{"key":"e_1_2_14_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(89)90083-4"},{"issue":"51","key":"e_1_2_14_59_2","first-page":"2723","article-title":"Liver\u2010protective action of silymarin therapy in chronic alcoholic liver diseases","volume":"130","author":"Feher J","year":"1989","journal-title":"Orv Hetil"},{"key":"e_1_2_14_60_2","doi-asserted-by":"publisher","DOI":"10.5414\/CPP40002"},{"issue":"2","key":"e_1_2_14_61_2","first-page":"X229","article-title":"Controlled prospective study on the effects of silymarin\u2010treatment on patients with cirrhosis of the liver","volume":"1","author":"Ferenci P","year":"1985","journal-title":"J Hepatol"},{"issue":"4","key":"e_1_2_14_62_2","first-page":"790","article-title":"Treatment with silymarin in patients with cirrhosis of the liver \u2013 results of a controlled prospective study and of the post study surveillance","volume":"6","author":"Ferenci P","year":"1986","journal-title":"Hepatology"},{"issue":"17","key":"e_1_2_14_63_2","first-page":"1419","article-title":"Effect of misoprostol on the course of viral hepatitis B","volume":"44","author":"Flisiak R","year":"1997","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"e_1_2_14_64_2","first-page":"S100","article-title":"Therapeutic effect of silipide in patients with chronic hepatitis C non\u2010responders (NTs) to interferon (IFN) treatment","volume":"21","author":"Buzzelli G","year":"1994","journal-title":"J Hepatol"},{"key":"e_1_2_14_65_2","first-page":"CD003181","article-title":"Bile acids for viral hepatitis. Cochrane Hepato\u2010Biliary Group","volume":"2","author":"Chen W","year":"2003","journal-title":"Cochrane Database Systemat Rev"},{"issue":"3","key":"e_1_2_14_66_2","first-page":"219","article-title":"Randomized open study of the dose\u2013effect relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis","volume":"64","author":"Vailati A","year":"1993","journal-title":"Fitoterapia"},{"issue":"30","key":"e_1_2_14_67_2","first-page":"1655","article-title":"Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C","volume":"141","author":"Par A","year":"2000","journal-title":"Orv Hetil"},{"key":"e_1_2_14_68_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27445"},{"key":"e_1_2_14_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03042201"},{"key":"e_1_2_14_70_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24100"},{"key":"e_1_2_14_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(02)80088-9"},{"key":"e_1_2_14_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07124-4"},{"key":"e_1_2_14_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510330230"},{"key":"e_1_2_14_74_2","author":"NCCAM","journal-title":"Evaluating Silymarin for Chronic Hepatitis C"},{"key":"e_1_2_14_75_2","author":"NCCAM","journal-title":"IdB 1016 Treatment for Hepatitis C Disease"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2005.00636.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2893.2005.00636.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T23:59:38Z","timestamp":1736035178000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2005.00636.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1111\/j.1365-2893.2005.00636.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2005.00636.x","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}